Mounjaro
US$ 26.10
dr now glp 1 Younan Nowzaradan, aka Dr. | Instagram Live Q&A - GLP-1, Surgery Options, Skin Surgery and more For Informational purposes only. Not intended as medical advice. #drnowmd GLP-Wonder
Description
Results The first cohort included 36082 GLP-1 receptor agonist users (median follow-up 1.3 years) and 234028 DPP-4 inhibitor users (median follow-up 1.7 years)
While their benefits for diabetes and obesity are well-documented, their impact on cardiovascular health is a topic of growing interest
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), initially developed for the treatment of type 2 diabetes and obesity, may modulate pathways associated with the hallmarks of aging
Low energy availability increases stress load and reduces recovery capacity
